Supreme Court to Review Abortion Pill Access Regulations

Here is a rewritten version of the news article in a neutral newsroom style:

Several pharmaceutical companies have filed an emergency appeal with the US Supreme Court, seeking to restore access to abortion pills by mail. The companies, which manufacture mifepristone, a medication used in medical abortions, are asking the court to reconsider its recent ruling that blocks telehealth and mail access to the pill.

The companies claim that their products have been affected by the court’s decision, which was issued earlier this year. As a result, they are seeking an emergency stay of the ruling to allow them to continue providing their medication to patients through telehealth services and mail delivery.

The Supreme Court has received multiple petitions from pharmaceutical companies, including those from Pfizer, Merck, and Teva Pharmaceuticals. The companies argue that the court’s decision would have significant economic and social impacts on their businesses and customers.

The US Department of Justice has declined to comment on the matter, but the American Medical Association and other medical organizations have expressed support for the pharmaceutical companies’ appeal.

Source: Google News World